Dr. Reddy's Laboratories

Dr. Reddy's Laboratories

Multinational pharmaceutical company that develops and manufactures innovative and medicines to improve patient health

Founded

1984

Headquarters

Hyderabad (India)

Status

Public

Company Details

Website

Socials

Email

Phone

+91-4049002900

Dr. Reddy's Laboratories is a prominent Indian multinational pharmaceutical company based in Hyderabad, India. Here's an overview of the company:

Overview

  • Founding and History: Dr. Reddy's Laboratories was founded in 1984 by Kallam Anji Reddy. Initially, it focused on producing active pharmaceutical ingredients (APIs) and later expanded into branded formulations and generics.

  • Headquarters: The company is headquartered in Hyderabad, Telangana, India.

Products and Services

  • Product Portfolio: Dr. Reddy's offers a wide range of pharmaceutical products, including:

    • APIs: Active pharmaceutical ingredients for drug manufacture.

    • Generics: Affordable versions of branded drugs.

    • Branded Generics: Branded versions of generic drugs.

    • Biosimilars: Similar versions of biologic drugs.

    • OTC Products: Over-the-counter medications.

  • Therapeutic Areas: The company focuses on several therapeutic areas, including:

    • Gastroenterology

    • Cardiovascular

    • Diabetology

    • Oncology

    • Pain Management

    • Dermatology

Operations and Expansion

  • Manufacturing Facilities: Dr. Reddy's operates 23 manufacturing facilities and 9 R&D facilities globally.

  • International Presence: The company markets its products in over 53 countries and sells to 76 nations, including major markets like the US, Europe, and emerging markets in Asia and Latin America.

  • Research and Development: Dr. Reddy's has a strong R&D focus, with significant investments in new drug discovery and development of novel therapeutics.

Milestones and Achievements

  • Early Successes: Dr. Reddy's was among the first Indian companies to export APIs to Europe and the US. It was also the first Indian pharma firm to out-license a novel drug to an innovator firm.

  • Partnerships and Collaborations: The company has collaborated with various international partners, including a partnership with the Russian Direct Investment Fund for the Sputnik V COVID-19 vaccine.

Financial Performance

  • Revenue Growth: Dr. Reddy's has experienced steady revenue growth, with significant contributions from its generics and APIs segments.

  • Market Position: The company holds a prominent position in the global generics market, offering affordable, high-quality medicines worldwide.

Overall, Dr. Reddy's Laboratories is a leading player in the global pharmaceutical industry, known for its commitment to providing affordable and innovative medicines.

Key People

Erez Israeli

Kallam Anji Reddy

Archana Bhaskar

Chandra Kumar Verma

Key Metrics

Total Equity Funding

-

No. of Funding Rounds

2

Latest Funding Round

N/A

Post Money Valuation

-

as of N/A

Funding Multiple

-

as of N/A

Investors

Amgen Business Development

and 5 more

Employee Count

28000

Similar Companies

Granules India

Exit Details

Public

All Funding Rounds

No funding rounds available

Recent News